In patients with CKD, serum levels of Fetuin-A are significantly reduced [199,200], and several studies have shown that, in this population, reduced circulating levels of Fetuin-A are associated with increased all-cause and cardiovascular mortality [201,202]. The gene discussed is AHSG; the disease is chronic kidney disease.